The global virus filtrationmarket is expected to reach
USD 6.1 billion by 2025, according to a new report by Grand View Research, Inc.
The market is expected to witness a CAGR of 12.5% over the forecast period,
increasing demand for biological products such as vaccines, therapeutic
proteins, blood & blood products, cellular & gene therapy, tissue, and
stem cell products is a major factor driving market growth. Biopharmaceuticals
are mainly derived from human, animal, and plants and therefore require a
scrutinized virus filtration procedure to avoid virus contamination in the
production. Therefore, the necessity of this procedure during the production of
biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are
involved in R&D to develop innovative biological products. For instance, in
2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8%
more than the R&D investment in 2015. This investment was mainly undertaken
to boost innovation and productivity in R&D to accomplish a sustainable
pipeline of vaccines and differentiated therapies with lucrative commercial
opportunities. Virus filtration is an important step in biologics development, thus,
the increasing R&D on biologics is expected to drive the demand for these
products.
Full Research Report On virus filtration market Analysis:
Further Key Findings From the Report Suggest:
·
The consumables segment was the largest
revenue generating segment of the market in 2016 owing to the increased usage
of consumables including reagents, kits, and membranes in biologics downstream
processing
·
In the technology segment, the
chromatography segment is projected to grow at the highest growth rate during
the forecast period. This is because of product advancements such as disposable
or single-use membranes that eliminate the risk of a potential virus
contaminant
·
The biologicals segment accounted for the
largest share of the market and is projected to maintain its dominance during
the forecast period due to rising prevalence of chronic diseases such as
cancer, blood disorders, and diabetes
·
The biopharmaceutical & biotechnology
companies segment is projected to grow at the highest CAGR during the forecast
period because of increasing investment in R&D and production of biologics
·
North America dominated the overall market
in 2016 primarily due to the presence of several leading biotechnology
companies and increased R&D activities for the development of biologics
·
The Asia Pacific market is estimated to
grow at the highest CAGR during the forecast period. Growing presence of CROs
in Asia Pacific countries including China and India due to the presence of a
large genome pool, less stringent regulations, and availability of economical
labor force is contributing to the growth of this region.
·
Some of the major players are Merck KGaA;
Sartorius; Danaher; Thermo Fisher Scientific, Inc.; Charles River Laboratories
International, Inc.; GE Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi
PharmaTech (Cayman) Inc.; Lonza; and Clean Cells
View More Reports
Of This Category By Grand View Research At:
https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global virus filtration market on
the basis of product, technology, application, end-use, and region:
Virus
Filtration Product Outlook (Revenue, USD Million; 2014 - 2025)
·
Consumables
o Kits and reagents
o Others
·
Instruments
o Filtration systems
o Chromatography systems
·
Services
Virus Filtration
Technology Outlook (Revenue, USD Million; 2014 - 2025)
·
Filtration
·
Chromatography
Virus Filtration
Application Outlook (Revenue, USD Million; 2014 - 2025)
·
Biologicals
o Vaccines and therapeutics
o Blood and blood products
o Cellular and gene therapy products
o Tissue and tissue products
o Stem cell products
·
Medical devices
·
Water purification
·
Air purification
Virus Filtration
End-use Outlook (Revenue, USD Million; 2014 - 2025)
·
Biopharmaceutical & biotechnology
companies
·
Contract research organizations
·
Medical devices companies
·
Academic institutes & research
laboratories
Virus Filtration
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
o France
o Italy
o Spain
·
Asia Pacific
o Japan
o China
o India
·
Latin America
o Brazil
o Mexico
·
MEA
o South Africa
o Saudi Arabia
Access Full Press
Release of this Report: https://www.grandviewresearch.com/press-release/global-virus-filtration-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
https://www.grandviewresearch.com/
